文献速递心力衰竭与心肌病

射血分数降低型心力衰竭恶化管理:JACC焦点研讨会3/3

Management of Worsening Heart Failure With Reduced Ejection Fraction: JACC Focus Seminar 3/3.
PubMed 文献 · J Am Coll Cardiol · 2023-01-01

本文针对射血分数降低型心力衰竭(HFrEF)恶化患者,虽无专门指南但证据快速更新,提出管理框架:处理淤血、管理诱因、快速序贯同时或住院启动四联药物(至少四药低剂量),并考虑维利西呱(五联)及静脉铁剂。

要点

  • HFrEF恶化患者应优先处理淤血和管理诱因。
  • 快速序贯或同时启动四联药物,至少四药低剂量。
  • 铁缺乏者可考虑静脉铁剂,并考虑维利西呱(五联)。

核心结论

  • 对HFrEF恶化患者应像对待急症一样积极管理,尽快建立四联药物基础并考虑维利西呱和静脉铁剂。

研究设计与样本

  • JACC焦点研讨会综述,基于近期临床试验证据提出管理框架。

主要发现

  • 近期多项临床试验显示多种疗法在高危HFrEF恶化人群中安全有效。
  • 目前尚无针对HFrEF恶化患者的专门临床实践指南。

关键数值与推荐

  • 四联药物至少使用所有4种药物的低剂量。
  • 铁缺乏者可考虑静脉铁剂,并考虑 upfront 同时使用维利西呱(五联)。

临床怎么用

  • 处理淤血和管理诱因后,快速序贯、同时或住院启动四联药物,优先保证四药低剂量。
  • 对铁缺乏者给予静脉铁剂,并考虑加用维利西呱以进一步降低残余风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Despite worsening heart failure (HF) being extremely common, expensive, and associated with substantial risk of death, there remain no dedicated clinical practice guidelines for the specific management of these patients. The lack of a management guideline is despite a rapidly evolving evidence-base, as a number of recent clinical trials have demonstrated multiple therapies to be safe and efficacious in this high-risk population. Herein, we propose a framework for treating worsening HF with reduced ejection fraction with the sense of urgency it deserves. This includes treating congestion; managing precipitants; and establishing a foundation of rapid-sequence, simultaneous, and/or in-hospital initiation of quadruple medical therapy for HF with reduced ejection fraction, with the top priority being at least low doses of all 4 medications. Moreover, to maximally reduce residual clinical risk, we further propose consideration of upfront simultaneous use of vericiguat (ie, quintuple medical therapy) and administration of intravenous iron for those who are iron deficient.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Greene, Bauersachs, Brugts, et al. Management of Worsening Heart Failure With Reduced Ejection Fraction: JACC Focus Seminar 3/3. J Am Coll Cardiol. 2023. PMID: 37532426. doi:10.1016/j.jacc.2023.04.057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。